Carregant...
Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
BACKGROUND: Proprotein convertase subtilisin/kexin 9 (PCSK9) is an important regulator of low-density lipoprotein receptor (LDLR) and plasma levels of LDL cholesterol (LDL-C). PCSK9 inhibition is an efficient therapeutic approach for the treatment of dyslipidemia. We tested the therapeutic effect of...
Guardat en:
| Publicat a: | BMC Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902459/ https://ncbi.nlm.nih.gov/pubmed/31818299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-019-1457-8 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|